Botanical species · safety record

Astragalus complanatus

The EFSA Compendium of Botanicals holds 5 constituent measurements for Astragalus complanatus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Astragalus complanatus Bunge

5Constituent measurements

0Safety records

4Cited sources

3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Astragalus complanatus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Seed(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Calycosin	Seed	—	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Calycosin	Seed	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Camphor	Seed	—	6 Percent	GC-MS	No resolvable identifier
Formononetin	Seed	—	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Saponins	Seed	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Pu, Yan-nan., Tang, Li-ying., Wang, Zhu-ju., Zhu, Jie., Cui, Yuan-jun., Chen, Sui-qing. Determination of three flavonoids in seeds of Astragali complanati by HPLC.. Zhongguo shiyan fangjixue zazhi, 2011, vol. 17, no. 10, p. 89-91.
Wu, Xiao., Liu, Yin-fang., Liu, Chun-yu. Study on chemical constituents of Semen Astragali Complanati.. Anhui zhongyiyao daxue xuebao, 2014, vol. 33, no. 3, p. 91-94.
Guo, Sheng-nan., Lu, Jin-qing., Cai, Jun-long., Li, Qiang., Liang, Huan. Analysis of volatile constituents of Astragali Complanati semen by HS-SPME combined with GC-MS.. Zhongyaocai, 2013, vol. 36, no. 12, p. 1966-1968.
CUI, BL., SAKAI, Y., TAKESHITA, T., KINJO, J., NOHARA, T. 4 NEW OLEANENE DERIVATIVES FROM THE SEEDS OF ASTRAGALUS-COMPLANATUS. CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, vol. 40, no. 1, p. 136-138.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature